Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Profiles will have a brief outage at 6pm this Friday, 5/30/2025, for system upgrade.

Philip Sung-En Wang, Dr.P.H., M.D.

Concepts (353)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Mental Health Services	18	2010	1723	1.360	Why?
Antidepressive Agents	12	2010	2897	1.260	Why?
Mental Disorders	26	2010	6853	1.140	Why?
Depressive Disorder	10	2010	3714	1.050	Why?
Antipsychotic Agents	13	2009	3076	1.020	Why?
Community Mental Health Services	3	2010	381	0.760	Why?
National Institute of Mental Health (U.S.)	3	2010	107	0.730	Why?
Suicide, Attempted	5	2010	1409	0.710	Why?
Health Services Research	9	2010	1808	0.630	Why?
Health Surveys	17	2009	4056	0.620	Why?
Absenteeism	6	2008	246	0.620	Why?
Depression	9	2022	8237	0.540	Why?
Suicide	4	2010	1604	0.540	Why?
Cost Sharing	2	2010	409	0.490	Why?
Mood Disorders	7	2010	1128	0.480	Why?
Health Services Needs and Demand	7	2010	1406	0.470	Why?
Work	2	2006	195	0.460	Why?
Psychotropic Drugs	4	2009	879	0.450	Why?
Clozapine	4	2007	509	0.430	Why?
Health Policy	5	2010	2698	0.430	Why?
Pharmacogenetics	2	2009	682	0.420	Why?
Comorbidity	20	2022	10563	0.380	Why?
Cost-Benefit Analysis	8	2010	5526	0.380	Why?
Disasters	2	2007	520	0.380	Why?
Patient Compliance	5	2005	2692	0.370	Why?
Adolescent Health Services	2	2010	217	0.350	Why?
Antihypertensive Agents	3	2005	2033	0.340	Why?
British Columbia	6	2010	237	0.340	Why?
Drug Prescriptions	7	2006	1662	0.330	Why?
Substance-Related Disorders	7	2010	4416	0.320	Why?
Cost of Illness	4	2009	1950	0.300	Why?
Efficiency	3	2007	480	0.290	Why?
Depressive Disorder, Major	8	2009	4808	0.290	Why?
Employer Health Costs	1	2006	21	0.280	Why?
World Health Organization	3	2009	1328	0.270	Why?
Hip Fractures	2	2005	997	0.260	Why?
Drug Therapy	2	2008	504	0.260	Why?
School Health Services	1	2010	387	0.260	Why?
Psychotic Disorders	7	2009	3270	0.250	Why?
Community-Institutional Relations	1	2007	209	0.250	Why?
United States	38	2010	72903	0.250	Why?
Prevalence	16	2022	15842	0.240	Why?
Medication Systems	1	2005	32	0.240	Why?
Task Performance and Analysis	2	2006	770	0.240	Why?
Arrhythmias, Cardiac	2	2007	2247	0.240	Why?
Health Care Surveys	4	2007	2424	0.240	Why?
Drug Costs	2	2010	1193	0.240	Why?
Behavioral Symptoms	1	2006	187	0.230	Why?
Schizophrenia	4	2009	6972	0.230	Why?
Workplace	2	2008	873	0.230	Why?
Child Health Services	1	2010	645	0.230	Why?
Lung Diseases, Obstructive	1	2005	309	0.230	Why?
Drug Discovery	2	2010	1064	0.230	Why?
Delivery of Health Care	7	2010	5370	0.220	Why?
Chronic Disease	7	2022	9347	0.220	Why?
Neurosciences	1	2008	385	0.220	Why?
Digoxin	1	2004	246	0.210	Why?
Mortality	4	2007	2904	0.210	Why?
Commerce	1	2008	611	0.200	Why?
Humans	95	2022	765968	0.200	Why?
Medicare	8	2009	6823	0.200	Why?
Clergy	1	2003	79	0.200	Why?
Managed Care Programs	1	2007	934	0.190	Why?
Narcotics	1	2004	332	0.190	Why?
Parasympatholytics	1	2002	89	0.190	Why?
Dopamine Antagonists	1	2002	278	0.190	Why?
Urban Population	1	2010	2040	0.190	Why?
Adolescent	30	2010	88835	0.190	Why?
Specialization	1	2006	777	0.190	Why?
Lipoproteins, HDL	1	2005	674	0.180	Why?
Bipolar Disorder	3	2007	5138	0.180	Why?
Muscarinic Antagonists	1	2002	133	0.180	Why?
Evidence-Based Medicine	3	2010	3685	0.180	Why?
Insurance Claim Review	2	2004	746	0.180	Why?
Occupational Health	1	2007	813	0.180	Why?
Cholinergic Antagonists	1	2002	165	0.180	Why?
Male	59	2010	363698	0.180	Why?
Osteoarthritis	2	2006	1051	0.180	Why?
Employment	2	2008	1106	0.180	Why?
Psychiatric Status Rating Scales	8	2007	6014	0.180	Why?
Female	61	2010	396112	0.170	Why?
New Jersey	7	2006	296	0.170	Why?
Patient Dropouts	3	2009	410	0.170	Why?
Fluvoxamine	2	2010	77	0.170	Why?
Gastrointestinal Diseases	2	2006	1203	0.170	Why?
Logistic Models	10	2007	13266	0.170	Why?
Anti-Arrhythmia Agents	1	2004	769	0.170	Why?
Death, Sudden	1	2002	300	0.170	Why?
Health Services Accessibility	6	2010	5508	0.170	Why?
Central Nervous System Diseases	1	2004	518	0.160	Why?
Patient Care Team	2	2010	2517	0.160	Why?
Population Surveillance	2	2007	2590	0.160	Why?
Paroxetine	2	2010	180	0.160	Why?
Aged	38	2022	171117	0.160	Why?
Adult	38	2010	223044	0.150	Why?
Markov Chains	4	2006	968	0.150	Why?
Medicine	1	2006	942	0.150	Why?
Clinical Trials as Topic	3	2010	8041	0.150	Why?
Louisiana	2	2007	104	0.150	Why?
Cross-Sectional Studies	12	2010	26318	0.140	Why?
Quality of Health Care	3	2010	4300	0.140	Why?
Medicaid	4	2007	2833	0.140	Why?
Middle Aged	35	2010	223009	0.140	Why?
Hypertension	5	2005	8626	0.140	Why?
Urinary Incontinence	1	2002	491	0.140	Why?
Citalopram	2	2010	402	0.140	Why?
Hypnotics and Sedatives	1	2005	1191	0.140	Why?
Survivors	1	2007	2372	0.140	Why?
Randomized Controlled Trials as Topic	3	2009	10383	0.140	Why?
Cohort Studies	13	2010	41649	0.140	Why?
Quality-Adjusted Life Years	4	2009	1737	0.130	Why?
Cholesterol	1	2005	2898	0.130	Why?
Biomedical Research	2	2010	3458	0.130	Why?
Age of Onset	4	2008	3344	0.130	Why?
Fluoxetine	2	2010	729	0.130	Why?
Research Support as Topic	2	2010	696	0.130	Why?
Osteoporosis	1	2005	1582	0.130	Why?
Risk Assessment	8	2009	24282	0.130	Why?
Health Care Costs	1	2009	3242	0.130	Why?
Bone Density	2	2005	3491	0.130	Why?
Severity of Illness Index	7	2009	15880	0.120	Why?
Adrenal Cortex Hormones	1	2004	1880	0.120	Why?
Health Status	2	2006	4080	0.120	Why?
Decision Support Systems, Clinical	1	2004	1175	0.120	Why?
Models, Theoretical	1	2006	3564	0.120	Why?
Risk	5	2010	9591	0.120	Why?
Aged, 80 and over	18	2010	59489	0.120	Why?
Diagnostic and Statistical Manual of Mental Disorders	6	2007	1989	0.120	Why?
Cause of Death	4	2010	3708	0.110	Why?
Occupations	2	2006	516	0.110	Why?
Patient Acceptance of Health Care	3	2007	3230	0.110	Why?
Income	4	2008	1874	0.110	Why?
Complementary Therapies	3	2009	487	0.110	Why?
Anxiety	3	2022	4671	0.110	Why?
Family Practice	2	2006	508	0.110	Why?
Proportional Hazards Models	5	2010	12509	0.100	Why?
Mexico	3	2010	777	0.100	Why?
Benzodiazepines	3	2007	1136	0.100	Why?
Probability	6	2009	2475	0.100	Why?
Sampling Studies	2	2004	607	0.100	Why?
Age Distribution	2	2008	2858	0.100	Why?
Anxiety Disorders	5	2009	2737	0.100	Why?
Costs and Cost Analysis	2	2007	1668	0.090	Why?
Drug Utilization	5	2009	1187	0.080	Why?
Treatment Outcome	8	2010	65188	0.080	Why?
Pennsylvania	6	2007	614	0.080	Why?
Diagnosis, Dual (Psychiatry)	3	2007	300	0.080	Why?
Risk Factors	13	2010	74840	0.080	Why?
Needs Assessment	2	2007	1138	0.080	Why?
Drug Utilization Review	2	2007	248	0.080	Why?
Health Planning Guidelines	1	2010	151	0.080	Why?
Insurance, Pharmaceutical Services	2	2009	347	0.080	Why?
Interviews as Topic	2	2008	2739	0.080	Why?
Sertraline	1	2010	209	0.080	Why?
Prescription Fees	1	2010	153	0.080	Why?
Pharmacoepidemiology	3	2007	351	0.080	Why?
Public Health	1	2002	2680	0.080	Why?
Diabetes Mellitus	3	2005	5891	0.080	Why?
Self Care	2	2004	800	0.080	Why?
Utilization Review	1	2010	381	0.080	Why?
Odds Ratio	4	2008	9649	0.070	Why?
Anti-Inflammatory Agents, Non-Steroidal	3	2006	2268	0.070	Why?
Imipramine	1	2008	94	0.070	Why?
Dementia	3	2007	2744	0.070	Why?
Cyclooxygenase 2 Inhibitors	2	2006	318	0.070	Why?
Therapies, Investigational	1	2008	110	0.070	Why?
Dibenzothiazepines	1	2007	101	0.070	Why?
Ambulatory Care	2	2009	2778	0.070	Why?
Southeastern United States	1	2007	94	0.070	Why?
Adrenergic Uptake Inhibitors	1	2008	187	0.070	Why?
Activities of Daily Living	2	2007	2415	0.070	Why?
Chi-Square Distribution	2	2003	3432	0.070	Why?
National Health Programs	1	2010	443	0.070	Why?
Prepaid Health Plans	1	2006	9	0.070	Why?
Mass Screening	3	2007	5446	0.060	Why?
Pharmaceutical Services	1	2007	145	0.060	Why?
Multivariate Analysis	5	2007	12056	0.060	Why?
Health Services Misuse	1	2007	245	0.060	Why?
Stroke	1	2007	9747	0.060	Why?
Risperidone	1	2007	383	0.060	Why?
Allied Health Personnel	1	2007	156	0.060	Why?
Drug Evaluation	1	2006	641	0.060	Why?
Hospitals, Psychiatric	1	2006	317	0.060	Why?
Comparative Effectiveness Research	1	2010	714	0.060	Why?
Health Services for the Aged	1	2007	265	0.060	Why?
Child	8	2010	80564	0.060	Why?
Retrospective Studies	9	2022	81514	0.060	Why?
Death Certificates	1	2006	170	0.060	Why?
Databases, Factual	3	2010	8067	0.060	Why?
Administration, Oral	3	2008	4015	0.060	Why?
Pravastatin	2	2006	391	0.060	Why?
Salaries and Fringe Benefits	1	2006	258	0.060	Why?
Quinolones	1	2007	387	0.060	Why?
Self-Injurious Behavior	1	2010	570	0.060	Why?
Telephone	1	2007	627	0.060	Why?
Remission Induction	1	2009	2411	0.050	Why?
Patient Education as Topic	2	2004	2334	0.050	Why?
Psychiatry	2	2006	1714	0.050	Why?
Patient Care Management	1	2006	303	0.050	Why?
Treatment Failure	1	2009	2652	0.050	Why?
Public Health Informatics	1	2004	109	0.050	Why?
Risk Adjustment	2	2004	596	0.050	Why?
Angiotensin II Type 1 Receptor Blockers	1	2005	429	0.050	Why?
Product Surveillance, Postmarketing	1	2007	464	0.050	Why?
Direct Service Costs	1	2002	61	0.050	Why?
Secondary Prevention	1	2009	1472	0.050	Why?
Early Diagnosis	1	2008	1187	0.050	Why?
Role	1	2003	176	0.050	Why?
Lipoproteins, LDL	1	2005	643	0.050	Why?
Research Design	2	2009	6209	0.050	Why?
Life Change Events	1	2007	954	0.050	Why?
Age Factors	5	2009	18380	0.050	Why?
Longitudinal Studies	2	2009	14751	0.050	Why?
Monitoring, Physiologic	1	2009	1792	0.050	Why?
Disaster Planning	1	2007	559	0.050	Why?
Hypolipidemic Agents	1	2006	608	0.050	Why?
Hospitals, Veterans	1	2004	395	0.050	Why?
Reimbursement Mechanisms	1	2007	672	0.050	Why?
Arthritis	2	2004	677	0.050	Why?
Hyperlipidemias	1	2006	770	0.050	Why?
Time Factors	4	2009	40065	0.050	Why?
Calibration	1	2003	814	0.050	Why?
Geriatric Assessment	1	2009	1429	0.050	Why?
Health Maintenance Organizations	1	2004	656	0.050	Why?
Psychotherapy	2	2007	1645	0.040	Why?
Confidence Intervals	2	2006	2910	0.040	Why?
Prolactin	1	2002	625	0.040	Why?
Hospital Costs	1	2006	956	0.040	Why?
Social Class	1	2009	2007	0.040	Why?
Quality Assurance, Health Care	2	2010	2172	0.040	Why?
Hospitalization	2	2010	10808	0.040	Why?
Thiazoles	1	2007	1529	0.040	Why?
Marital Status	1	2002	426	0.040	Why?
Medical Records Systems, Computerized	1	2006	1195	0.040	Why?
Treatment Refusal	1	2003	433	0.040	Why?
Data Collection	1	2009	3318	0.040	Why?
Anticholesteremic Agents	2	2006	970	0.040	Why?
Efficiency, Organizational	1	2003	697	0.040	Why?
Medical Records	1	2004	1409	0.040	Why?
Government Programs	1	2021	278	0.040	Why?
Referral and Consultation	2	2010	3615	0.040	Why?
Angiotensin-Converting Enzyme Inhibitors	1	2005	1514	0.040	Why?
Education	1	2002	533	0.040	Why?
Life Expectancy	1	2005	1247	0.040	Why?
Breast Neoplasms	2	2003	21056	0.040	Why?
Alcoholism	1	2009	1975	0.040	Why?
Tamoxifen	1	2003	963	0.040	Why?
Occupational Exposure	1	2008	1805	0.040	Why?
Medication Adherence	1	2009	2192	0.040	Why?
Internal Medicine	1	2005	1064	0.040	Why?
Canada	3	2010	2119	0.040	Why?
Insurance Coverage	1	2009	1944	0.040	Why?
Cross-Over Studies	1	2004	2108	0.040	Why?
Models, Statistical	2	2009	5089	0.040	Why?
Poverty	1	2009	2714	0.040	Why?
Sensitivity and Specificity	2	2010	14652	0.040	Why?
Low Back Pain	1	2006	987	0.040	Why?
Socioeconomic Factors	3	2008	7838	0.040	Why?
Case-Control Studies	3	2004	22223	0.030	Why?
Piperazines	1	2007	2549	0.030	Why?
Sulfonamides	1	2006	1984	0.030	Why?
Insurance, Psychiatric	2	2009	65	0.030	Why?
Pyrazoles	1	2006	2033	0.030	Why?
Quality of Life	2	2009	13462	0.030	Why?
Sex Factors	2	2008	10603	0.030	Why?
Decision Support Techniques	1	2005	2003	0.030	Why?
Guideline Adherence	1	2005	2243	0.030	Why?
Interpersonal Relations	1	2002	1432	0.030	Why?
Dose-Response Relationship, Drug	2	2008	10729	0.030	Why?
Antineoplastic Agents, Hormonal	1	2003	1534	0.030	Why?
Linear Models	1	2004	5876	0.030	Why?
Insurance, Health	1	2006	2521	0.030	Why?
Health Expenditures	1	2007	2387	0.030	Why?
Nursing Homes	1	2002	1084	0.030	Why?
Attention	1	2004	2419	0.030	Why?
Diagnosis-Related Groups	2	2007	445	0.030	Why?
Follow-Up Studies	2	2006	39193	0.030	Why?
Pulmonary Disease, Chronic Obstructive	2	2005	3247	0.030	Why?
Pyridines	1	2005	2888	0.030	Why?
Circadian Rhythm	1	2004	2592	0.030	Why?
Stress, Psychological	1	2008	4533	0.030	Why?
Interview, Psychological	2	2008	812	0.030	Why?
Social Support	1	2002	2192	0.020	Why?
Regression Analysis	3	2007	6322	0.020	Why?
Reproducibility of Results	5	2008	20124	0.020	Why?
International Classification of Diseases	2	2010	935	0.020	Why?
Ontario	2	2002	402	0.020	Why?
Epidemiologic Studies	2	2006	677	0.020	Why?
Alzheimer Disease	2	2009	8730	0.020	Why?
Arthritis, Rheumatoid	1	2006	3733	0.020	Why?
Gastrointestinal Tract	2	2006	834	0.020	Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors	1	2005	3251	0.020	Why?
Primary Health Care	1	2006	4736	0.020	Why?
Analgesics, Opioid	1	2006	3835	0.020	Why?
Asthma	2	2005	6270	0.020	Why?
Clinical Coding	1	2010	190	0.020	Why?
Parents	1	2002	3592	0.020	Why?
Cardiovascular Diseases	4	2008	15652	0.020	Why?
Mental Health	1	2022	3278	0.020	Why?
Diclofenac	1	2006	68	0.020	Why?
Organizational Case Studies	1	2007	299	0.020	Why?
Naproxen	1	2006	99	0.020	Why?
Attitude to Health	2	2007	2020	0.020	Why?
Young Adult	5	2010	59889	0.020	Why?
Myocardial Infarction	1	2006	11499	0.020	Why?
Antidepressive Agents, Tricyclic	1	2007	426	0.020	Why?
Ibuprofen	1	2006	228	0.020	Why?
Forecasting	2	2004	2936	0.010	Why?
Lactones	1	2006	316	0.010	Why?
State Government	1	2007	388	0.010	Why?
Sulfones	1	2006	447	0.010	Why?
Data Interpretation, Statistical	2	2004	2686	0.010	Why?
Scotland	1	2002	115	0.010	Why?
Respiratory Tract Diseases	1	2008	744	0.010	Why?
Insurance Claim Reporting	1	2003	166	0.010	Why?
Ireland	1	2002	170	0.010	Why?
Life Tables	1	2002	363	0.010	Why?
Combined Modality Therapy	2	2006	8529	0.010	Why?
Software Design	1	2002	173	0.010	Why?
Heart Murmurs	1	2002	92	0.010	Why?
Demography	1	2007	1641	0.010	Why?
Prostatic Neoplasms	1	2004	11083	0.010	Why?
Developed Countries	1	2004	452	0.010	Why?
Pandemics	1	2021	8703	0.010	Why?
Self-Assessment	1	2003	400	0.010	Why?
Patient-Centered Care	1	2010	1458	0.010	Why?
Rheumatic Diseases	1	2006	622	0.010	Why?
Drug Approval	1	2007	818	0.010	Why?
Antineoplastic Agents	1	2002	13648	0.010	Why?
Health Services	1	2004	756	0.010	Why?
Drug Therapy, Combination	1	2008	6309	0.010	Why?
Netherlands	1	2002	2277	0.010	Why?
Nervous System Diseases	1	2008	1660	0.010	Why?
Multicenter Studies as Topic	1	2002	1731	0.010	Why?
Neoplasms	2	2005	22340	0.010	Why?
Medically Uninsured	1	2002	838	0.010	Why?
Delirium	1	2008	1707	0.010	Why?
Animals	1	2008	168764	0.010	Why?
Disability Evaluation	1	2003	1820	0.010	Why?
Postmenopause	1	2005	2515	0.010	Why?
Myocardial Ischemia	1	2006	2128	0.010	Why?
Prostate-Specific Antigen	1	2004	2464	0.010	Why?
Program Evaluation	1	2003	2499	0.010	Why?
Mastectomy	1	2003	1847	0.010	Why?
Chemotherapy, Adjuvant	1	2003	3537	0.010	Why?
Predictive Value of Tests	1	2010	15398	0.010	Why?
Developing Countries	1	2004	2911	0.010	Why?
Algorithms	1	2010	14071	0.010	Why?
Practice Guidelines as Topic	1	2005	7425	0.000	Why?
Pain	1	2003	5077	0.000	Why?
Obesity	1	2005	13076	0.000	Why?
Infant	1	2002	36386	0.000	Why?
Child, Preschool	1	2002	42500	0.000	Why?

Wang's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (353)

Explore

Co-Authors (31)

Explore

Similar People (60)

Explore

Same Department

Explore